Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2025-01-22 00:00:00 ET · period of report 2025-01-17 · accession 0001805688-25-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-22 | 2025-01-17 | JAZZ | Pearce Samantha | EVP, Chief Commercial Off | A - Grant | $0.00 | +2,533 | 26.8K | +10% | $0 | |
| 2025-01-22 | 2025-01-17 | JAZZ | Pearce Samantha | EVP, Chief Commercial Off | F - Tax | $122.62 | -1,365 | 25.4K | -5% | -$167.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-01-17 | A | A | 2,533 | $0.00 | 26,777 | D | — | — | (F2) The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 29, 2024. |
| 2 | Common | Ordinary Shares | 2025-01-17 | F | D | 1,365 | $122.62 | 25,412 | D | — | — |